UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Kinase Fusion Gene:MAP3K2_WBP2NL |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
Kinase Fusion partner gene information | Kinase Fusion gene name: MAP3K2_WBP2NL | KinaseFusionDB ID: KFG3397 | FusionGDB2.0 ID: KFG3397 | Hgene | Tgene | Gene symbol | MAP3K2 | WBP2NL | Gene ID | 10746 | 164684 | |
Gene name | mitogen-activated protein kinase kinase kinase 2 | WBP2 N-terminal like | ||||||||||
Synonyms | MEKK2|MEKK2B | GRAMD7|PAWP | ||||||||||
Cytomap | 2q14.3 | 22q13.2 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | mitogen-activated protein kinase kinase kinase 2MAP/ERK kinase kinase 2MAPK/ERK kinase kinase 2MEK kinase 2MEKK 2 | postacrosomal sheath WW domain-binding proteinWW domain-binding protein 2-like | ||||||||||
Modification date | 20240305 | 20240305 | ||||||||||
UniProtAcc | Q9Y2U5 | Q6ICG8 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000344908, ENST00000409947, | ENST00000328823, ENST00000461730, ENST00000543212, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: MAP3K2 [Title/Abstract] AND WBP2NL [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | MAP3K2(128056517)-WBP2NL(42420503), # samples:1 |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MAP3K2 | GO:0035556 | intracellular signal transduction | 14515274 |
Tgene | WBP2NL | GO:0051480 | regulation of cytosolic calcium ion concentration | 26116451 |
Kinase Fusion gene breakpoints across MAP3K2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across WBP2NL (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChiTaRS5.0 | BF215608 | MAP3K2 | chr2 | 128056517 | WBP2NL | chr22 | 42420503 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:128056517/:42420503) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
MAP3K2 | WBP2NL |
FUNCTION: Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. {ECO:0000250, ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:16001074}. | FUNCTION: May play a role in meiotic resumption and pronuclear formation, mediated by a WW domain-signaling pathway during fertilization. {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of MAP3K2_WBP2NL |
Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
MAP3K2 | Q9Y2U5 | human | CTNNB1 | P35222 | S675 | QDykKRLsVELtsSL | |
MAP3K2 | Q9Y2U5 | human | STK38 | Q15208 | S91 | LGLEDFEsLkVIGRG | Pkinase |
MAP3K2 | Q9Y2U5 | human | IRF3 | Q14653 | S173 | PCPQPLRsPsLDNPt |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
Kinase | GOID | GO term | P.adjust |
MAP3K2 | ID | Description | 0.00e+00 |
MAP3K2 | GO:0043123 | positive regulation of canonical NF-kappaB signal transduction | 2.38e-02 |
MAP3K2 | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 2.38e-02 |
MAP3K2 | GO:0007249 | canonical NF-kappaB signal transduction | 2.38e-02 |
MAP3K2 | GO:0031400 | negative regulation of protein modification process | 2.38e-02 |
MAP3K2 | GO:0007440 | foregut morphogenesis | 2.38e-02 |
MAP3K2 | GO:0043587 | tongue morphogenesis | 2.38e-02 |
MAP3K2 | GO:0048263 | determination of dorsal identity | 2.38e-02 |
MAP3K2 | GO:0048664 | neuron fate determination | 2.38e-02 |
MAP3K2 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 2.38e-02 |
MAP3K2 | GO:0003263 | cardioblast proliferation | 2.38e-02 |
MAP3K2 | GO:0003264 | regulation of cardioblast proliferation | 2.38e-02 |
MAP3K2 | GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.38e-02 |
MAP3K2 | GO:0033234 | negative regulation of protein sumoylation | 2.38e-02 |
MAP3K2 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 2.38e-02 |
MAP3K2 | GO:0039530 | MDA-5 signaling pathway | 2.38e-02 |
MAP3K2 | GO:0044848 | biological phase | 2.38e-02 |
MAP3K2 | GO:0048262 | determination of dorsal/ventral asymmetry | 2.38e-02 |
MAP3K2 | GO:0060272 | embryonic skeletal joint morphogenesis | 2.38e-02 |
MAP3K2 | GO:0060439 | trachea morphogenesis | 2.38e-02 |
MAP3K2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development | 2.38e-02 |
MAP3K2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development | 2.38e-02 |
MAP3K2 | GO:0070601 | centromeric sister chromatid cohesion | 2.38e-02 |
MAP3K2 | GO:0003306 | Wnt signaling pathway involved in heart development | 2.38e-02 |
MAP3K2 | GO:0009950 | dorsal/ventral axis specification | 2.38e-02 |
MAP3K2 | GO:0035112 | genitalia morphogenesis | 2.38e-02 |
MAP3K2 | GO:0060788 | ectodermal placode formation | 2.38e-02 |
MAP3K2 | GO:0071697 | ectodermal placode morphogenesis | 2.38e-02 |
MAP3K2 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation | 2.38e-02 |
MAP3K2 | GO:0072497 | mesenchymal stem cell differentiation | 2.38e-02 |
MAP3K2 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation | 2.38e-02 |
MAP3K2 | GO:0050808 | synapse organization | 2.38e-02 |
MAP3K2 | GO:0021781 | glial cell fate commitment | 2.38e-02 |
MAP3K2 | GO:0034333 | adherens junction assembly | 2.38e-02 |
MAP3K2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | 2.38e-02 |
MAP3K2 | GO:0021819 | layer formation in cerebral cortex | 2.38e-02 |
MAP3K2 | GO:0042762 | regulation of sulfur metabolic process | 2.38e-02 |
MAP3K2 | GO:0048715 | negative regulation of oligodendrocyte differentiation | 2.38e-02 |
MAP3K2 | GO:0071696 | ectodermal placode development | 2.38e-02 |
MAP3K2 | GO:0071888 | macrophage apoptotic process | 2.38e-02 |
MAP3K2 | GO:0072160 | nephron tubule epithelial cell differentiation | 2.38e-02 |
MAP3K2 | GO:0072283 | metanephric renal vesicle morphogenesis | 2.38e-02 |
MAP3K2 | GO:2000288 | positive regulation of myoblast proliferation | 2.38e-02 |
MAP3K2 | GO:0001711 | endodermal cell fate commitment | 2.38e-02 |
MAP3K2 | GO:0010457 | centriole-centriole cohesion | 2.38e-02 |
MAP3K2 | GO:0048820 | hair follicle maturation | 2.38e-02 |
MAP3K2 | GO:0060572 | morphogenesis of an epithelial bud | 2.38e-02 |
MAP3K2 | GO:0072498 | embryonic skeletal joint development | 2.38e-02 |
MAP3K2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 2.38e-02 |
MAP3K2 | GO:0060856 | establishment of blood-brain barrier | 2.38e-02 |
Top |
Related Drugs to MAP3K2_WBP2NL |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning MAP3K2-WBP2NL and kinase inhibitors the PubMed Abstract (04-01-2024) |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to MAP3K2_WBP2NL |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |